MedPath

Observational study on clinical outcome prediction of anti-epidermal growth factor receptor for colorectal cancer based on DNA methylation status and gene expression status.

Not Applicable
Conditions
Metastatic colorectal cancer
Registration Number
JPRN-UMIN000027296
Lead Sponsor
Institute of Development, Aging and Cancer (IDAC), Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
159
Inclusion Criteria

Not provided

Exclusion Criteria

Cases with mutations in KRAS are excluded from the subject.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PFS (Progression Free Survival) / RR (Response Rate)
Secondary Outcome Measures
NameTimeMethod
OS (Overall Survival)
© Copyright 2025. All Rights Reserved by MedPath